OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
17.03
-0.15 (-0.87%)
Oct 25, 2024, 4:00 PM EDT - Market closed
OnKure Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 7.33 | 4.82 | 3.9 |
| Research & Development | 36.4 | 32.12 | 25.86 |
| Operating Expenses | 43.72 | 36.93 | 29.77 |
| Operating Income | -43.72 | -36.93 | -29.77 |
| Interest & Investment Income | 1.63 | 1.62 | 0.25 |
| Pretax Income | -42.12 | -35.31 | -29.51 |
| Net Income | -42.12 | -35.31 | -29.51 |
| Net Income to Common | -42.12 | -35.31 | -29.51 |
| Shares Outstanding (Basic) | 1 | 1 | - |
| Shares Outstanding (Diluted) | 1 | 1 | - |
| EPS (Basic) | -31.63 | -29.32 | - |
| EPS (Diluted) | -31.63 | -29.32 | - |
| Free Cash Flow | -36.2 | -34.79 | -28.09 |
| Free Cash Flow Per Share | -27.18 | -28.89 | - |
| EBITDA | -43.28 | -36.52 | -29.54 |
| D&A For EBITDA | 0.45 | 0.42 | 0.23 |
| EBIT | -43.72 | -36.93 | -29.77 |
Source: S&P Capital IQ. Standard template.
Financial Sources.